Carol Gail Ashe insider trades

Open-market stock purchases and sales by Carol Gail Ashe, Director at Elicio Therapeutics, Inc, from SEC Form 4 filings since Jan 2, 2019.

Recent trades

DateStockTradeValue
Aug 31, 2026ELTX Elicio Therapeutics, IncBought (not open market)—

Companies traded

  • ELTX Elicio Therapeutics, Inc: other filings, last Aug 31, 2026
  • APTO Aptose Biosciences Inc: other filings, last Feb 5, 2024

Get free alerts when Carol Gail Ashe files a new trade →